Related Experiment Video
Updated: Jun 12, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Microtubule destruction induces tau liberation and its subsequent phosphorylation
Tomohiro Miyasaka1, Sinji Sato, Yoshitaka Tatebayashi
1Laboratory for Alzheimer's Disease, Brain Science Institute, The Institute of Physical and Chemical Research (RIKEN),Wako-shi, Saitama, Japan. tomiyasa@mail.doshisha.ac.jp
Abstract:
Neurofibrillary tangle-bearing neurons, a pathological hallmark of Alzheimer's disease, are mostly devoid of normal microtubule (MT) structure and instead have paired helical filaments that are composed of abnormal hyperphosphorylated tau. However, a causal relationship between tau phosphorylation and MT disruption has not been clarified. To examine whether MT disruption induces tau phosphorylation, stathmin, an MT-disrupting protein, was co-expressed with tau in COS-7 cells. Stathmin expression induced apparent MT catastrophe and tau hyperphosphorylation at Thr-181, Ser-202, Thr-205, and Thr-231 sites. In contrast, c-Jun N-terminal kinase activation, or phosphatase inhibition, led to significant tau phosphorylation without affecting MT structure. These findings suggest that MT disruption induces subsequent tau phosphorylation.
Insights
Microtubule (MT) disruption, not tau phosphorylation, may initiate Alzheimer's disease pathology. Studies show MT breakdown triggers tau hyperphosphorylation, suggesting a new therapeutic target for Alzheimer's disease.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) is characterized by neurofibrillary tangles composed of hyperphosphorylated tau protein.
- The relationship between tau phosphorylation and microtubule (MT) disruption in AD pathogenesis remains unclear.
Purpose of the Study:
- To investigate whether microtubule (MT) disruption can induce tau phosphorylation.
- To elucidate the causal link between MT structure and tau pathology in Alzheimer's disease.
Main Methods:
- Co-expression of stathmin (an MT-disrupting protein) and tau in COS-7 cells.
- Analysis of MT structure and tau phosphorylation at specific sites (Thr-181, Ser-202, Thr-205, Thr-231).
- Comparison with effects of c-Jun N-terminal kinase activation and phosphatase inhibition on tau phosphorylation.
Main Results:
- Stathmin expression caused significant MT disruption (catastrophe).
- MT disruption induced by stathmin led to hyperphosphorylation of tau at key Alzheimer's disease-associated sites.
- c-Jun N-terminal kinase activation or phosphatase inhibition caused tau phosphorylation without affecting MT structure.
Conclusions:
- Microtubule (MT) disruption appears to be an upstream event that induces tau hyperphosphorylation.
- These findings suggest that preserving MT stability may be a potential therapeutic strategy for Alzheimer's disease.
Related Concept Videos
Destabilization of Microtubules
Microtubule Instability
Microtubule Instability
Microtubule Associated Proteins (MAPs)
Drugs that Stabilize Microtubules
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...

